Corvus Pharmaceuticals Inc buy melinda
Start price
26.04.18
/
50%
€8.85
Target price
26.04.18
€9.92
Performance (%)
0.00%
End price
26.04.18
€8.85
Summary
This prediction ended on 26.04.18 with a price of €8.85. melinda's BUY prediction for Corvus Pharmaceuticals Inc closed unchanged from the start price. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Corvus Pharmaceuticals Inc | 7.595% | 7.595% | -34.615% | -3.774% |
iShares Core DAX® | -0.268% | 5.471% | 14.271% | 19.027% |
iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% | 58.415% |
iShares Nikkei 225® | 0.284% | 1.729% | 9.943% | 7.045% |
iShares S&P 500 | 1.178% | 5.269% | 27.989% | 49.400% |
Comments by melinda for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
SektorBiotechnologische und medizinische Forschung
Corvus Pharmaceuticals gibt den Start der klinischen Phase 1 / 1b-Studie des experimentellen Anti-CD73-Antikörpers CPI-006 bei Patienten mit fortgeschrittenem Krebs bekannt
In einer dreiarmigen Studie wird CPI-006 als Monotherapie in Kombination mit dem Adenosinantagonisten CPI-444 und in Kombination mit Pembrolizumab untersucht
(Vom Mitglied beendet)
Stopped prediction by melinda for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€8.88
26.04.18
26.04.18
€9.92
21.05.18
21.05.18
13.06%
21.05.18
21.05.18
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€8.02
04.03.18
04.03.18
€10.10
12.03.18
12.03.18
10.91%
12.03.18
12.03.18